Urinary Tract Infection: Current Treatment and Future Options

Dear Colleagues,

Urinary infections, including cystitis, pyelonephritis, and other urinary tract infections (UTIs), represent a significant public health concern, affecting millions globally. These infections are predominantly caused by bacterial pathogens such as Escherichia coli. Their prevalence is influenced by a variety of factors, including personal hygiene practices, sexual activity, and underlying health conditions. UTIs are notably more common in women due to anatomical predispositions, but they also pose substantial health risks to men, particularly in the elderly population.

The cornerstone of UTI treatment is antibiotic therapy, with a spectrum of antimicrobial agents available to target specific bacterial strains. However, the escalating issue of antibiotic resistance is complicating the management of these infections, necessitating the exploration of alternative therapeutic strategies. Current research is increasingly focusing on adjunctive therapies such as probiotics, herbal medicine, and immunotherapeutics to both prevent and treat urinary infections.

This Special Issue of the Journal of Clinical Medicine is dedicated to presenting cutting-edge research and developments in the field of urinary infection management. We invite submissions that offer novel insights into therapeutic innovations, address the challenges posed by antibiotic resistance, and highlight advancements in diagnostic technologies.

You may choose our Joint Special Issue in Uro.

Dr. Biagio Barone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.